Abivax SA American Depositary Shares

Yahoo Finance • 5 hours ago

ABIVAX (ABVX) Appoints Michael Nesrallah as Chief Commercial Officer

ABIVAX Société Anonyme (NASDAQ:ABVX) is one of the 7 Best Strong Buy European Stocks to Invest In. On April 2, 2026, ABIVAX Société Anonyme (NASDAQ:ABVX) appointed Michael Nesrallah as chief commercial officer. Michael Nesrallah will lead... Full story

Yahoo Finance • 11 days ago

Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies

Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies Abivax publishes financial reports with the French and U.S. securities regulatory agencies PARIS, France – April 1, 2026 – 10:05 PM CEST – Abivax... Full story

Yahoo Finance • 17 days ago

2 Healthcare Stocks That Could Soar Over the Next 5 Years

Key Points These two biotechs could ride the wave of significant clinical progress. However, both carry above-average risk. 10 stocks we like better than Moderna › While the stock market is facing significant volatility right now, there... Full story

Yahoo Finance • 27 days ago

Biotech Stock Up Nearly 300% Draws $68.7 Million Bet as Breast Cancer Drug Targets 2027 Launch

Key Points Cormorant Asset Management established a new stake in Olema Pharmaceuticals, purchasing 2,750,000 shares in the fourth quarter. The value of the position was $68.75 million at quarter-end. The new position places Olema outside... Full story

Yahoo Finance • 27 days ago

This Biotech Stock Surged 75% Last Quarter and Pulled a New $9 Million Investment

Key Points Eversept Partners added 264,468 shares of Vera Therapeutics in the fourth quarter; the estimated transaction value was $9.39 million based on quarterly average pricing. Meanwhile, the quarter-end position value increased in val... Full story

Yahoo Finance • 28 days ago

AstraZeneca Abivax Talks Highlight Biotech Expansion And Valuation Upside Potential

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. AstraZeneca (LSE:AZN) has entered exclusive negotiations to potentially acquire biotech firm Abi... Full story

Yahoo Finance • 30 days ago

Eli Lilly Could Rejoin Abivax Bidding If AstraZeneca Misses Deadline

British drugmaker AstraZeneca Plc has emerged as the leading contender to acquire French biotech Abivax SA, following the company's dramatic valuation surge after strong clinical progress tied to its lead drug candidate. The potential tak... Full story

Yahoo Finance • last month

Sector Update: Health Care Stocks Retreat Late Afternoon

Health care stocks declined late Thursday afternoon, with the NYSE Health Care Index down 1.3% and t PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • last month

Sector Update: Health Care Stocks Lower in Afternoon Trading

Health care stocks declined Thursday afternoon, with the NYSE Health Care Index and the State Street PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 2 months ago

Qualcomm, Booking Holdings upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Loop Capital upgraded Qualcomm (QCOM)... Full story

Yahoo Finance • 2 months ago

Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026

Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026 22 abstracts presented at European Crohn’s and Colitis Organization’s (... Full story

Yahoo Finance • 2 months ago

Biotech Stock Up 266%: This New $55 Million Bet Signals Conviction in Praxis Amid Pipeline Progress

On February 13, 2026, Affinity Asset Advisors disclosed a new position in Praxis Precision Medicines(NASDAQ:PRAX), acquiring 185,000 shares in an estimated $54.53 million trade. What happened According to a SEC filing dated February 13,... Full story

Yahoo Finance • 2 months ago

Apogee Stock Jumps 87% in One Year as This Biotech Fund Lifts Stake to $93 Million

On February 13, 2026, Affinity Asset Advisors disclosed a purchase of 61,500 shares of Apogee Therapeutics(NASDAQ:APGE), an estimated $3.87 million trade based on quarterly average pricing. What happened According to an SEC filing dated... Full story

Yahoo Finance • 2 months ago

ABIVAX Société Anonyme (ABVX) Share Momentum Builds Amid Takeover Speculation and Advancing Therapeutic Programs

ABIVAX Société Anonyme (NASDAQ:ABVX) is one of the 11 Best Performing Stocks in the Last 12 Months.ABIVAX Société Anonyme (ABVX) Share Momentum Builds Amid Takeover Speculation and Advancing Therapeutic Programs A dose bottle of the medic... Full story

Yahoo Finance • 3 months ago

Is ABIVAX Société Anonyme (ABVX) One of the Hottest Large-Cap Stocks of 2025?

ABIVAX Société Anonyme (NASDAQ:ABVX) is one of the hottest large-cap stocks of 2025. On December 16, Piper Sandler raised the firm’s price target on Abivax to $142 from $112, while maintaining an Overweight rating on the shares. On the sa... Full story

Yahoo Finance • 4 months ago

Here are the most and least likely M&A targets in biotech, according to Truist

[M&A - concept waiting for mergers and acquisitions.3D rendering on yellow background.] French biotech (ABVX [https://seekingalpha.com/symbol/ABVX]) has emerged as the most likely acquisition target among biotechs in 2026, significantly o... Full story

Yahoo Finance • 4 months ago

Sector Update: Health Care Stocks Higher Late Afternoon

Health care stocks advanced late Monday afternoon with the NYSE Health Care Index rising 0.6% and th PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 4 months ago

Sector Update: Health Care Stocks Higher in Afternoon Trading

Health care stocks advanced Monday afternoon, with the NYSE Health Care Index up 0.5% and the State PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • 4 months ago

Is Rapport Therapeutics Stock a Buy After Investment Firm Cormorant Raised Its Stake Over $60 Million?

Key Points Cormorant Asset Management added 251,600 shares in Rapport Therapeutics; the reported position value increased by approximately $61.38 million over the prior quarter. The change represents 0.31% of Cormorant’s reportable 13F as... Full story

Yahoo Finance • 4 months ago

Abivax soars on report of Eli Lilly meeting French officials over possible deal

Investing.com -- Abivax shares jumped after fresh media reports revived speculation that U.S. drugmaker Eli Lilly is exploring a takeover of the French biotech company. The stock was up 9% in Paris by 04:21 ET (09:21 GMT) on Monday, while... Full story